EDITORIAL
Accepted on 10 Mar 2025
Debates in Experimental Pharmacology and Drug Discovery 2023: Innovative Approaches to Chronic Kidney Disease Drug Discovery, Identification of Targets, and Safety Assessment
doi 10.3389/fphar.2025.1588367
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Debates in Experimental Pharmacology and Drug Discovery 2023: Innovative Approaches to Chronic Kidney Disease Drug Discovery, Identification of Targets and Safety Assessment
Debates in Experimental Pharmacology and Drug Discovery 2023: Innovative Approaches to Chronic Kidney Disease Drug Discovery, Identification of Targets and Safety Assessment
4,814
Total downloads
18k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 21 Feb 2025
Astragalus-containing Chinese herbal medicine used with Western medicine for lupus nephritis: a systematic review and meta-analysis of randomized controlled trials
doi 10.3389/fphar.2024.1395844
- 748 views
REVIEW
Published on 17 Jul 2024
Mapping the global research landscape on depression for patients with chronic kidney disease: a bibliometric and visualized analysis from 2006 to 2022
doi 10.3389/fphar.2024.1388641
- 1,166 views
- 2 citations
ORIGINAL RESEARCH
Published on 19 Mar 2024
Unraveling DDIT4 in the VDR-mTOR pathway: a novel target for drug discovery in diabetic kidney disease
doi 10.3389/fphar.2024.1344113
- 1,375 views
- 4 citations
ORIGINAL RESEARCH
Published on 01 Feb 2024
Annona Muricata L. extract restores renal function, oxidative stress, immunohistochemical structure, and gene expression of TNF-α, IL-β1, and CYP2E1 in the kidney of DMBA-intoxicated rats
doi 10.3389/fphar.2024.1348145
- 4,886 views
- 1 citation
ORIGINAL RESEARCH
Published on 16 Nov 2023
BM-MSCs alleviate diabetic nephropathy in male rats by regulating ER stress, oxidative stress, inflammation, and apoptotic pathways
doi 10.3389/fphar.2023.1265230
- 2,372 views
- 4 citations
ORIGINAL RESEARCH
Published on 21 Oct 2022
Nephropathy 1st inhibits renal fibrosis by activating the PPARγ signaling pathway
doi 10.3389/fphar.2022.992421
- 1,539 views
- 1 citation
ORIGINAL RESEARCH
Published on 29 Sep 2022
Multi-omics analysis reveals the pathogenesis of db/db mice diabetic kidney disease and the treatment mechanisms of multi-bioactive compounds combination from Salvia miltiorrhiza
doi 10.3389/fphar.2022.987668
- 2,798 views
- 4 citations
